ונקומיצין – פרזניוס 1000 מג ישראל - עברית - Ministry of Health

ונקומיצין – פרזניוס 1000 מג

neopharm (israel) 1996 ltd - vancomycin as hydrochloride - vancomycin as hydrochloride 1000 mg - vancomycin

ונקומיצין – פרזניוס 500 מג ישראל - עברית - Ministry of Health

ונקומיצין – פרזניוס 500 מג

neopharm (israel) 1996 ltd - vancomycin as hydrochloride - vancomycin as hydrochloride 500 mg - vancomycin

פריוריקס ישראל - עברית - Ministry of Health

פריוריקס

glaxo smith kline (israel) ltd - live attenuated measles virus; live attenuated mumps virus; live attenuated rubella virus - אבקה וממס להכנת תמיסה להזרקה - live attenuated mumps virus 10^3.7 ccid50; live attenuated rubella virus 10^3.0 ccid50; live attenuated measles virus 10^3.0 ccid50 - rubella, combinations with mumps, live attenuated - rubella, combinations with mumps, live attenuated - priorix is indicated for active immunisation of children from the age of 9 months or older, adolescents and adults against measles, mumps and rubella.

פריוריקס טטרה ישראל - עברית - Ministry of Health

פריוריקס טטרה

glaxo smith kline (israel) ltd - live attenuated measles virus; live attenuated mumps virus; live attenuated rubella virus; live attenuated varicella virus - אבקה וממס להכנת תמיסה להזרקה - live attenuated measles virus 10^ 3.0 ccid50; live attenuated mumps virus 10^ 4.4 ccid50; live attenuated rubella virus 10^ 3.0 ccid50; live attenuated varicella virus 10^ 3.3 pfu - measles, combinations with mumps, rubella and varicella, live attenuated - measles, combinations with mumps, rubella and varicella, live attenuated - priorix-tetra is indicated for active immunisation against measles, mumps, rubella and varicella in children from the age of 12 months up and including 12 years of age.

ELLA - Stent Systems for Gastrointestinal Tract, Endovascular Stent Systems, Stent Extractors ישראל - עברית - Ministry of Health

ella - stent systems for gastrointestinal tract, endovascular stent systems, stent extractors

a.m.i. technologies, ltd. - מומחה - תומכנים למערכת העיכול + תומכנים אנדו וסקולרים + נלווים

BellaContour ישראל - עברית - Ministry of Health

bellacontour

alfatech medical systems - אחר - מערכת לחיטוב הגוף הצרת היקפיים צמצום והעלמת צלוליט שיפור מרקם העור

אפקסור XR 75 ישראל - עברית - Ministry of Health

אפקסור xr 75

pfizer pfe pharmaceuticals israel ltd - venlafaxine as hydrochloride - קפסולות בשחרור נרחב - venlafaxine as hydrochloride 75 mg - venlafaxine - venlafaxine - for the treatment of depression. maintenance of recurrent depression. generalized anxiety disorder (gad) - short term and long-term. social anxiety disorder (sad).

אפקסור XR 150 ישראל - עברית - Ministry of Health

אפקסור xr 150

pfizer pfe pharmaceuticals israel ltd - venlafaxine as hydrochloride - קפסולות בשחרור נרחב - venlafaxine as hydrochloride 150 mg - venlafaxine - venlafaxine - for the treatment of depression. maintenance of recurrent depression. generalized anxiety disorder (gad) - short term and long-term. social anxiety disorder (sad).

בוטוקס 100 ישראל - עברית - Ministry of Health

בוטוקס 100

abbvie biopharmaceuticals ltd, israel - botulinum toxin type a - אבקה להכנת תמיסה לזריקה - botulinum toxin type a 100 u/vial - botulinum toxin - botulinum toxin - botox is indicated for the symptomatic relief of blepharospasm or vii nerve disorders in patients over 12 years hemifacial spasm and associated focal dystonias as well as the correction of strabismus in patients 12 years of age and above. botox is also indicated for the reduction of the signs and symptoms of spasmodic torticollis ( cervical dystonia) in adults. botox is also indicated for the treatment of dynamic equinus foot deformity due to spasticity in paediatric cerebral palsy patients two years of age or older. focal upper limb spasticity associated with stroke. botox is indicated also for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged 65 years or less. management of primary axillary hyperhidrosis in patients who failed other medical symptomatic treatment.symptom relief in adults fulfilling criteria for chronic migraine (headaches on ?15 days per month of which at least 8 days with migrai

בוטוקס 50 ישראל - עברית - Ministry of Health

בוטוקס 50

abbvie biopharmaceuticals ltd, israel - botulinum toxin type a - אבקה להכנת תמיסה לזריקה - botulinum toxin type a 50 u/vial - botulinum toxin - botulinum toxin - botox is indicated for the symptomatic relief of blepharospasm or vii nerve disorders in patients over 12 years hemifacial spasm and associated focal dystonias as well as the correction of strabismus in patients 12 years of age and above. botox is also indicated for the reduction of the signs and symptoms of spasmodic torticollis ( cervical dystonia) in adults. botox is also indicated for the treatment of dynamic equinus foot deformity due to spasticity in paediatric cerebral palsy patients two years of age or older. focal upper limb spasticity associated with stroke. botox is indicated also for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged 65 years or less. management of primary axillary hyperhidrosis in patients who failed other medical symptomatic treatment.symptom relief in adults fulfilling criteria for chronic migraine (headaches on ?15 days per month of which at least 8 days with migrai